Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00420407 · ClinicalTrials.gov registry record · Early Phase 1

Low Dose Vasopressin in Traumatic Shock

A Early Phase 1 study, sponsored by The University of Texas Health Science Center at San Antonio.

Terminated
Registry status
Early Phase 1
Development phase
81
Enrollment target

NCT00420407 is a Early Phase 1 study that was terminated before completion, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 81 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00420407, a Early Phase 1 study, was terminated before completion, sponsored by The University of Texas Health Science Center at San Antonio.

TERMINATED
Registry status
Early Phase 1
Development phase
81 participants
Enrollment target

Study Summary

Hypothesis: We hypothesize that resuscitation regimens which minimize the total volume of resuscitation fluid, while restoring organ perfusion, will lead to lower morbidity and mortality in critically ill patients following trauma.

Interventions

  • DRUG normal saline control
  • DRUG vasopressin

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2007-02
Est. Completion 2011-02
Phase Early Phase 1

What the Registry Record Tells You About NCT00420407

The ClinicalTrials.gov registry entry for NCT00420407 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which normal saline control is the first listed.

NCT00420407 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00420407 about?

NCT00420407 is a clinical study titled "Low Dose Vasopressin in Traumatic Shock". Hypothesis: We hypothesize that resuscitation regimens which minimize the total volume of resuscitation fluid, while restoring organ perfusion, will lead to lower morbidity and mortality in critically ill patients following trauma.

What is the current status of trial NCT00420407?

This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 81 participants. The study started on 2007-02. Estimated completion is 2011-02.

What interventions are being tested in trial NCT00420407?

The interventions under investigation include: normal saline control (DRUG), vasopressin (DRUG).

Who is sponsoring clinical trial NCT00420407?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.